Norachem

Curated by Signal

AI-based generative design platform to make novel drugs for specific diseases

Overview

AI-based generative design platform to make novel drugs for specific diseases. It combines deep learning, artificial intelligence, graph theory, computational geometry, and genetic programming to search a near-infinite chemical space and produce molecular structures with optimal values for multiple objectives.

Key facts

Founded: 2020
Headquarters: New York City, United States
Stage: Sign up to view
Industry: Health Technology

Business model

2 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Intel Health Media
Provider of an online health information platform for multiple health disorders
Health TechnologyLivonia, United States
Neolytica
Provider of AI-based medical affairs management software for the healthcare sector
Health TechnologyMorristown, United States
Pills Palace
Online pharmacy for the delivery of generic medicines
Health TechnologyGrandville, United States

About Norachem

What does Norachem do?

AI-based generative design platform to make novel drugs for specific diseases.

Where is Norachem headquartered?

Norachem is headquartered in New York City, United States.

When was Norachem founded?

Norachem was founded in 2020.

Which sector is Norachem in?

Norachem operates in Health Technology.

Who are Norachem's competitors?

Companies similar to Norachem include Intel Health Media, Neolytica, and Pills Palace.